Want to join the conversation?
$AMT 2Q15 Q&A: Prentiss of Raymond James asked about AFFO guidance increase. Thomas answered that on EBITDA side with adjusted updated outlook, there is $22MM of outperformance there, of which $17MM is cash. Actually generated some sizable interest savings and cash taxes is up a little bit vs. prior outlook to net to $15MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?